Treatment method with SR18662 considerably lowers advancement and proliferation of CRC cells. SR18662 exhibits enhanced efficacy in reducing viability of several CRC mobile strains. Flow cytometry Examination pursuing SR18662 treatment demonstrates an increase in cells captured in both S or G2/M phases on the mobile cycle and a significant increase https://emilys641inq4.59bloggers.com/profile